HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Inovio Pharmaceuticals, Inc. (INO)
23.72  2.79  (13.33%) 07-07 15:20
Open: 21.62 High: 24.99
Pre.close: 20.93 Low: 20.75
Volume: 57,440,661 Ave vol: 41,487,962
52w High: 33.79 52w Low: 1.92
MA(50): 16.783 MA(200): 9.244
EPS: -1.164 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.inovio.com
Market Cap (M): 3,750
Shares Out (M): 158
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat, cure, and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells and facilitate cross-strain protection against unmatched and matched pathogens. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bearish
KDJ: Bullish RSI: Bullish
Target 1: 39.47 Target 2: 46.10
Resist 1: 33.79 Resist 2: 39.47
Support 1: 19.79 Support 2: 11.13
Company key metrics
Revenue per Share: 0.0419
Net Income per Share: -1.2154
Cash per Share: 0.226
Book Value per Share: 0.035
Price to Sales: 111.2938
Price to Book Value: 133.2225
Earnings Yield: -0.2608
Dividend Yield: 0
Debt to Equity: 40.9061
Debt to Assets: 0.9761
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Neutral
Debt to Equity: Outperform
Stock Charts
Headline news
Tue, 07 Jul 2020
INO Stock News: Inovio Pharmaceuticals Inc. regains the $21.00 mark and above - FXStreet

Mon, 06 Jul 2020
INO Stock News: Inovio Pharmaceuticals Inc. seen opening with gains above $22.00 - FXStreet

Tue, 23 Jun 2020
Inovio Pharmaceuticals Inc (INO): Hedge Funds Are Snapping Up - Yahoo Finance

Tue, 30 Jun 2020
Why Inovio Pharmaceuticals Plunged 20% Today - Yahoo Finance

Sun, 28 Jun 2020
What Does The Future Hold For Inovio Pharmaceuticals, Inc. (NASDAQ:INO)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance

Fri, 26 Jun 2020
Why Inovio Pharmaceuticals (INO) Stock Jumped Over 700% This Year - Pulse 2.0

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.